Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers develop new approach to efficiently produce versatile antibody therapies

Researchers develop new approach to efficiently produce versatile antibody therapies

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Study finds low HPV vaccination rates among childhood cancer survivors

Study finds low HPV vaccination rates among childhood cancer survivors

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Bacterial infections may trigger dysregulation of blood formation

Bacterial infections may trigger dysregulation of blood formation

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Routine dental checkups offer opportunity to observe changes in patient’s health

Routine dental checkups offer opportunity to observe changes in patient’s health

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Xenotransplantation – organ transplants from animals may soon be a reality

Xenotransplantation – organ transplants from animals may soon be a reality

Study provides new insight into development of immune cells

Study provides new insight into development of immune cells

Researchers boost antimicrobial and anticancer properties of spider peptides

Researchers boost antimicrobial and anticancer properties of spider peptides

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

Neuroscientists uncover genetic basis for formation of meningiomas in childhood cancer survivors

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

Shaping the future of oncology treatment

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

DKFZ scientists reveal how cancer cells suppress immune system to spread and multiply

DKFZ scientists reveal how cancer cells suppress immune system to spread and multiply

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.